Similar articles

• Clinical predictors of bioterrorism-related inhalational anthrax.

  Gair R. Gair R. Lancet. 2005 Jan 15-21;365(9455):214-5; author reply 215. doi: 10.1016/S0140-6736(05)17737-X. Lancet. 2005. PMID: 15652599 No abstract available.
• Clinical predictors of bioterrorism-related inhalational anthrax.

  Kyriacou DN, Stein AC, Yarnold PR, Courtney DM, Nelson RR, Noskin GA, Handler JA, Frerichs RR. Kyriacou DN, et al. Lancet. 2004 Jul 31-Aug 6;364(9432):449-52. doi: 10.1016/S0140-6736(04)16769-X. Lancet. 2004. PMID: 15288744
• When bioterrorism strikes: diagnosis and management of inhalational anthrax.

  Shafazand S. Shafazand S. Semin Respir Infect. 2003 Sep;18(3):134-45. Semin Respir Infect. 2003. PMID: 14505276 Review.
• Index case of fatal inhalational anthrax due to bioterrorism in the United States.

  Bush LM, Abrams BH, Beall A, Johnson CC. Bush LM, et al. N Engl J Med. 2001 Nov 29;345(22):1607-10. doi: 10.1056/NEJMoa012948. Epub 2001 Nov 8. N Engl J Med. 2001. PMID: 11704685 No abstract available.
• Inhalational anthrax and bioterrorism.

  Quintiliani R Jr, Quintiliani R. Quintiliani R Jr, et al. Curr Opin Pulm Med. 2003 May;9(3):221-6. doi: 10.1097/00063198-200305000-00011. Curr Opin Pulm Med. 2003. PMID: 12682568 Review.